What the research says, and what it does not

Has BPC-157 been tested as a treatment in pet dogs?

Short answer: No. As of September 2026, no published study had tested BPC-157 or TB-500 as a treatment in pet dogs.

So there is no published answer, either way, on whether these help or harm a pet dog.

Then what are the dog studies people mention?

Short answer: They are lab studies in healthy beagles, done as early steps toward a wound drug for people.

One study tracked how fast a beagle's body clears BPC-157. Another looked for harm when lab dogs were given it again and again.

The beagles handled it well. The one change was a lower reading on one routine blood test, called creatinine, and only at the highest amount tested. It went back to normal about two weeks after the peptide was stopped.

Those dogs were not pets with sore joints or injuries. They got a clean batch made by the researchers, not a vial from a website. Doing well in a lab is not the same as being safe for your dog.

Do results in rats carry over to dogs?

Short answer: Not neatly.

Most BPC-157 research has been done in rats and mice. A 2026 review of the rat studies on one kind of injury called BPC-157 an idea worth more lab testing, not a proven treatment.

Bodies differ, too. In one study, about three times as much of an injected amount reached the blood in beagles as in rats.

So a result in a rat cannot tell anyone what the same product would do in a dog.

What about studies in people?

Short answer: They are few and small. A 2025 review found only three small early studies of BPC-157 in people, and it said the peptide is still being tested.

A 2026 review counted fewer than 30 people across those studies. None of them compared people who got BPC-157 with people who did not, so they cannot show whether it made a difference.

What about TB-500?

Short answer: TB-500 is a lab-made copy of a small piece of a protein the body makes on its own, called thymosin beta-4.

It spread as a product aimed at racehorses. It is banned in horse racing and horse sport, and racing labs built tests to catch it.

No study that tested TB-500 or thymosin beta-4 as a treatment in dogs was found.

And GHK-Cu or KPV?

Short answer: For KPV, no study in dogs, cats or horses was found at all.

For GHK-Cu, the closest dog study found dates from 1996. Researchers made small cuts in the paw pads of twelve lab dogs and injected a copper-bound peptide. Those pads built more of one kind of collagen, the tough material that helps skin knit back together, than pads given salt water.

The study never names the exact peptide, so it may not even be GHK-Cu. It is 30 years old, and it says nothing about joints, the gut or aging.

Are collagen chews the same thing?

Short answer: No. Both get called peptides, but they are very different products.

One study gave 31 dogs with arthritis a collagen peptide supplement by mouth, and their walking measures improved compared with a dummy treatment. A maker of the collagen paid for the study, and one author worked for that company.

That study says nothing about BPC-157 or other injected peptides. And a supplement is not an FDA-approved drug.